立即登录 | 免费注册
全部学科 | 内科学 | 心血管病学 | 内分泌学与糖尿病 | 神经病学 | 消化病学 | 呼吸病学 | 肿瘤学 | 妇产科学 | 骨科学
疾病中心: 高血压 | 冠心病 | 心力衰竭 | 心律失常 | 脂肪性肝病 | 糖尿病 | 卒中 | 慢性阻塞性肺病 | 子宫内膜异位症 | 乳腺癌 | 肺癌 | 结直肠癌 | 器官移植
Loading
当前位置:期刊中心 > 爱思唯尔期刊精选全文 > 文摘导读
母乳喂养早产婴儿的结局
Outcomes of Human Milk-Fed Premature Infants
Richard J. Schanler  |   2011/1/27 9:45:00 
Seminars in Perinatology  |   2011   |   Volume 35 Issue 1   |   打印| 推荐给好友
上一篇: 妇科肿瘤的溶瘤病毒疗法
下一篇: 孕早期和孕中期药物流产的疼痛控制:一项系统综述

Article Outline

Host Defense
Effects on Neurodevelopmental Outcome
Nutritional Status and Growth
Metabolic Syndrome
Conclusions
References

Host Defense

The relationship between diet and the incidence of infection in premature infants demonstrates that the feeding of mother's milk mitigates the high rate of infection common to hospitalized premature infants.3 A trial in the United Kingdom reported that necrotizing enterocolitis (NEC) was reduced significantly by feeding premature infants human milk, either exclusively or partially supplemented with either formula or pasteurized donor human milk.4 That study identified the greatest risk for NEC in the group of infants born before 28 weeks' gestation. When infants receiving a diet of human milk exclusively (mother's own milk or donor human milk) were compared with those receiving an infant formula-only diet, there was a 6.5-fold (95% confidence interval [CI] 1.9-22, P < 0.001) increase in confirmed cases of NEC as identified from surgical pathology or postmortem examination. A significant 3-fold (95% CI 1.4-6.5, P < 0.005) increase in NEC was also reported when an exclusive infant formula diet was compared with a diet of formula used as a supplement to human milk. The relationship between the dose of human milk and the protective effect was examined post-hoc from a study of 2 feeding strategies for premature infants, trophic feeding versus no feeding (4 vs 14 days) and tube-feeding method, continuous versus intermittent bolus.5 The study enrolled infants born before 30 weeks' gestation who were stratified in enrollment by diet, either mother's milk or preterm formula. Differences between groups favored early trophic feeding at 4 days using the intermittent bolus feeding method. However, for all measured outcomes, the type of milk fed was the most important variable. Infants fed predominantly human milk (averaged as more than 50 mL/kg/d, approximately one-third of full milk feedings) had significantly less late-onset sepsis and/or NEC and a 2-week shorter hospitalization compared with infants fed preterm formula. Late-onset sepsis and/or NEC had an even greater incidence if the study infants received a combination of mother's milk and preterm formula. The study identified a dose of human milk that potentially might be protective. This dose of mother's milk, >50 mL/kg/d, subsequently was shown to protect against late-onset sepsis in a 4 week study of premature infants when compared with average daily doses of 1-24 and 25-49 mL/kg and was also associated with greater survival free of NEC.[6] and [7] Similarly, a mother's milk dose of ≥50% of enteral feeding in the first 14 days was associated with an 83% reduction in NEC (OR 0.17, 95% CI 0.04-0.68) compared with premature infants receiving <50% of enteral feedings as mother's milk.8

NEC is a significant concern not only because of its high case–fatality ratio, but also because of implications for long-term outcome. The complications of stricture, short bowel syndrome, and cholestasis pose significant morbidity to the infant. Nutritional issues are significant because metabolism is shifted from growth to tissue repair. Therefore, long-term growth delays are noted, especially in infants with surgically-treated NEC. At follow-up between 18 and 22 months, growth was below the 10th percentile for weight in 70%, length in 48%, and head circumference in 39% of infant survivors of surgically-treated NEC.9 Neurodevelopment also may be affected in NEC survivors. More cases of cerebral palsy, mental and motor scores below 70, blindness, and deafness are reported in surgically-treated NEC survivors.9 White matter injury also is seen on magnetic resonance imaging scans in follow-up studies of premature infants surviving medically and surgically treated NEC.10

A predominantly human milk diet in the NICU is also associated with fewer hospital readmissions for illness up to 30 months after discharge in a study of over 1000 infants with mean birth weight of approximately 800 g and gestational age of 27 week.[11] and [12] When adjusted for important confounding variables, a NICU diet comprising more than 40 ml/kg/d of human milk (more than 40th percentile of human milk intake) is associated with a reduction in this rate of hospital readmission. For every 10 ml/kg/d, there is a 5% reduction in the rate of hospital readmission to 2 years.12 Other studies report that infants receiving the most human milk in the NICU also had fewer readmissions to the hospital after discharge.13 A smaller study reported that upper respiratory tract symptoms for their first year after discharge were less in those infants who received human milk in the NICU but who had a declining pattern of human milk feeding over the year.14 Thus, a human milk diet in the NICU is associated with a reduction in acute infection-related illnesses and also has persistent effects for at least 3 years after discharge.

Effects on Neurodevelopmental Outcome

The long-term neurodevelopment of premature infants is a concern and recent evidence suggests that the NICU diet may affect this outcome. An 8-year follow-up of 300 premature infants (approximately 1.4 kg and 31 weeks' gestation at birth) observed that even when factors affecting intelligence quotient (social class, maternal education, infant gender, and duration of mechanical ventilation) were considered in a regression model, the receipt of human milk in the NICU was associated with an 8-point IQ advantage, slightly more than 1 standard deviation of the mean.15 When followed to adolescence, this cohort was found to have verbal intelligence quotients that correlated positively with the percentage of expressed human milk they received as infants in the NICU.16 Furthermore, the percentage of expressed human milk received in the NICU also correlated significantly with total and white matter brain volumes measured by magnetic resonance imaging scans.16

Other cohorts of adolescents followed since their NICU stay as premature infants were reported to have significant cognitive and psychomotor benefits ascribed to the feeding of human milk in the NICU.[17], [18] and [19] In a large study of premature infants who were 30 weeks' gestation with a birth weight approximately 1.3-kg who were fed either human milk or preterm formula, a human milk diet was associated with significantly greater scores in behavioral visual acuity at 2-6 months corrected age compared with those fed a diet of preterm formula.13 The effect of human milk on cognitive indexes was also seen at 12 months corrected age and, in infants with chronic lung disease, a significant benefit of a human milk diet was observed for psychomotor indexes. Importantly, these observations were adjusted for Home Inventory, maternal intelligence testing, smoking, and birth weight.

A large multicenter follow-up study of 1035 extremely low birth weight infants who had extensive nutritional data collected during their hospitalization was conducted to determine the relationship between human milk intake in-hospital and neurodevelopmental outcome at 18-22 months of age.11 Neonatal birth weight, gestational age, intraventricular hemorrhage status, sepsis, bronchopulmonary dysplasia, and hospital stay were similar between those never receiving (25% of cohort) and those who received human milk (75% of cohort) during their hospitalization. There were differences in socioeconomic variables, race and ethnicity, educational attainment, and parity between groups. When adjusted for these variables as well as biological confounders, there were significantly positive effects for human milk intake on mental and motor development. The study found fewer infants with low mental and motor developmental scores and higher behavior rating score in the group receiving any human milk in the NICU. The magnitude of the effect was greatest in the highest-quintile (>80th percentile) group, which averaged a human milk intake of 110 mL/kg/d. The impact of feeding 100 mL/kg/d of human milk was an increase in the Bayley Mental Development Index score of 5 points (one-third of an SD) and an increase in Psychomotor Development Index of 6 points.11 Others have reported that even the 5-point difference on the Mental Development Index would have a significantly meaningful effect on the outcome of extremely low birth weight infants.20 These important observations on neurodevelopmental outcome at 18-22 months have been reported to persist to 30 months!12

The antioxidant effects of human milk may be associated with lower rates of retinopathy of prematurity (ROP) in premature infants. Fewer infants with severe ROP were fed predominantly human milk.21 We found significantly less stage III ROP in extremely preterm infants fed their own mother's milk (5.6%) compared with pasteurized donor human milk (19%) or preterm formula (14%), P = 0.05.22 In Japan, extremely preterm infants, 24 weeks' gestation and birth weights 600-700 g, with advanced ROP and retinal detachment, were less likely to have received human milk.23

There are many factors that might explain the associations between human milk feeding in premature infants and improved neurodevelopmental outcome. Many of the analyses were adjusted for important sociodemographic and parenting confounding variables. Few infants were actually breastfed, making the milk composition itself contributory to these outcomes. The combination of bioactive factors in human milk, rather than an individual factor, may account for the outcomes described.24 In addition, because human milk-fed premature infants experience fewer infection-related events, their better health likely contributes to the positive effects on neurodevelopmental outcome. Thus, because abnormal sensory-neural development is a significant long-term risk after premature birth, the use of mother's milk should be strongly encouraged in this population.

Nutritional Status and Growth

A large variation in the energy and protein contents of human milk brought to the NICU by the mother has been reported.25 Although the concentrations of protein, sodium, and zinc decline through lactation, the nutrient needs of the premature infant remain higher than those of term infants until sometime after term postmenstrual age. Indexes of protein nutritional status are lower and continue to decline over time when premature infants are fed unfortified human milk.26 Protein and energy supplementation are associated with improved rates of weight gain, nitrogen balance, and indexes of protein nutritional status.[26] and [27] Protein supplementation is important to improve short-term growth and long-term neurodevelopmental outcome.[28] and [29]

The absolute nutrient content of calcium and phosphorus in human milk is also inadequate for extremely premature infants. As a consequence of the low intakes of calcium and phosphorus, infants fed unfortified human milk have progressive decreases in serum phosphorus, increases in serum calcium, and increases in serum alkaline phosphatase activity compared with infants fed preterm formula containing adequate calcium and phosphorus.[30] and [31] Follow-up investigations of infants with extremely elevated serum alkaline phosphatase activity in the NICU found that at 18 months there was an inversely relationship to linear growth, infants having the highest alkaline phosphatase values had as much as a 2-cm reduction in linear growth.32 Evaluation of this cohort at 9-12 years of age found that the elevated neonatal serum alkaline phosphatase activity remained a significant predictor of attained height in adolescence.33 These data suggest that long-term mineralization might be affected by early neonatal diet. Supplementation with both calcium and phosphorus results in normalization of biochemical indexes of mineral status and improved linear growth and increased bone mineralization during and beyond the neonatal period.[30], [34] and [35]

As fortifiers adjust for nutrient inadequacies, the rates of growth in the NICU do increase. Moreover, the rate of growth in the NICU is significantly associated with long-term neurodevelopmental outcome.36

Metabolic Syndrome

There is increasing evidence that early nutrition programs long-term outcomes. Human milk feeding reduces the chance that premature infants will develop the metabolic syndrome, characterized by hypertension, obesity, and leptin and insulin resistance.37 A long-term study of premature infants was conducted in the United Kingdom. Infants were enrolled into 1 of 2 arms if their mothers elected not to provide breast milk. The study compared infants fed either donor human milk or preterm formula, diets characterized as low nutrient density vs high nutrient density. The infants had more rapid growth in neonatal period if fed the high nutrient density diet. Investigators found, however that the high nutrient density diet was associated with significant deleterious long-term effects. There was a dose response benefit through adolescence for those given human milk (low nutrient density), with lower rates of obesity, hypertension, low-density lipoprotein cholesterol, leptin resistance, and insulin resistance.[37], [38], [39] and [40] These data must be interpreted cautiously because, despite slow growth in the human milk-fed infants, they had “improved” brain development compared with infants receiving the greater nutrient density diets. Therefore, the goal should be to promote careful nutrition support but not excessive growth or nutrient intake.37 The optimal regimen(s) remain to be identified but will surely include predominantly, if not exclusively, some form of supplemented human milk.

Conclusions

There are significant host defense benefits from the feeding of mothers' own milk for premature infants, even extremely premature infants. It is unclear how much milk is protective or at what postnatal age the protective effects are maximal. The benefits of a human milk diet in the NICU are seen in fewer hospital readmissions for illness, improved growth and body composition, improved long-term sensory-neural development, and lower risk of metabolic syndrome. The mechanisms for these long-term beneficial effects remain the subject of speculation.

The various explanations certainly include the beneficial effects of maternal infant interaction and selection “bias” imposed by mother's choice to provide milk.15 The stimulatory effect of a nonhomogenous diet with variable taste and odor may affect sensory development.41 Specific nutrients may be associated with improved outcomes. The highly bioavailable protein in human milk may be responsible.11 The cholesterol in human milk may be responsible for long-term regulation of cholesterol metabolism or even myelin synthesis.[42] and [43] Polyunsaturated fatty acids have been implicated in improved brain and visual function.44 The long-chain oligosaccharide sugars have implications for host defense and gastrointestinal maturation, and improved neurodevelopmental outcome.45 The immunomodulation components of cells, immunoglobulins, cytokines, and growth factors also may play are role.24

Importantly, although there have been studies and suggestions to isolate single components from human milk to demonstrate a biological outcome, more likely it is the multiplicity of components in the milk that act together to protect and stimulate the infant host (Table 1).
 

Significant benefits to infant host defense, gastrointestinal maturation, sensory-neural development, and the quality of their nutritional status are observed when premature infants are fed human milk.1 Nonetheless, the nutritional adequacy of mother's milk on the basis of intrauterine rates of growth and nutrient accretion may be a limiting factor in the very low birthweight (VLBW) infant weighing <1500 g at birth.2 The overall nutritional needs of the VLBW infant are now met if a nutrient supplement, or fortifier, is added to the milk. The long-term effects of a human milk diet in the neonatal intensive care unit (NICU) recently are being appreciated. There are significant long-term benefits to this diet on improvements in host defense, neurodevelopmental outcome, nutritional status, and a reduction in the metabolic syndrome. The objective of this review is to describe the data that support these associations.
 
Table 1. Likely Reasons Why Human Milk Promotes Improved Long-Term Outcomes
Unknown
Maternal−infant interactions
Selection of breastfeeding (mother's choice)
Nonhomogeneity of milk composition
Taste, odor of milk
Specific nutrients
Polyunsaturated fatty acids (ie, long-chain polyunsaturated fatty acids)
Docosahexaenoic acid
Arachidonic acid
Cholesterol
Protein quality, quantity
Taurine, glutamine
Oligosaccharides, “Prebiotics”
Enzymes
Bile salt-stimulated lipase
Acetylhydrolase
Micronutrients (iodine, iron, zinc, selenium)
Specific factors
Immunoglobulin A, G
Lactoferrin
Lysozyme
Nucleotides
Antioxidants
Growth factors (nerve growth factor, insulin-like growth factor)
Cytokines (eg, interleukein-10)
Better host defense
 

References

1 Y. Morales and R.J. Schanler, Human milk and clinical outcomes in VLBW infants: how compelling is the evidence of benefit?, Semin Perinatol 31 (2007), pp. 83–88. Article | PDF (111 K) | View Record in Scopus | Cited By in Scopus (8)

2 E.E. Ziegler, A.M. O'Donnell and S.E. Nelson et al., Body composition of the reference fetus, Growth 40 (1976), pp. 329–341. View Record in Scopus | Cited By in Scopus (175)

3 M.A. Hylander, D.M. Strobino and R. Dhanireddy, Human milk feedings and infection among very low birth weight infants, Pediatrics 102 (1998), p. e38. Full Text via CrossRef

4 A. Lucas and T.J. Cole, Breast milk and neonatal necrotizing enterocolitis, Lancet 336 (1990), pp. 1519–1523. Article | PDF (743 K) | View Record in Scopus | Cited By in Scopus (500)

5 R.J. Schanler, R.J. Shulman and C. Lau, Feeding strategies for premature infants: beneficial outcomes of feeding fortified human milk vs preterm formula, Pediatrics 103 (1999), pp. 1150–1157. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (216)

6 L. Furman, G. Taylor and N. Minich et al., The effect of maternal milk on neonatal morbidity of very low-birth-weight infants, Arch Pediatr Adolesc Med 157 (2003), pp. 66–71. View Record in Scopus | Cited By in Scopus (54)

7 J. Meinzen-Derr, B. Poindexter and L. Wrage et al., Role of human milk in extremely low birthweight infants' risk of necrotizing enterocolitis or death, J Perinatol 29 (2009), pp. 57–62. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (15)

8 P.M. Sisk, C.A. Lovelady and R.G. Dillard et al., Early human milk feeding is associated with a lower risk of necrotizing enterocolitis in very low birthweight infants, J Perinatol 27 (2007), pp. 428–433. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (31)

9 S.R. Hintz, D.E. Kendrick and B.J. Stoll et al., Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis, Pediatrics 115 (2005), pp. 696–703. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (108)

10 D.K. Shah, L.W. Doyle and P.J. Anderson et al., Adverse neurodevelopment in preterm infants with postnatal sepsis or necrotizing enterocolitis is mediated by white matter abnormalities on magnetic resonance imagine at term, J Pediatr 153 (2008), pp. 170–175.

11 B.R. Vohr, B.B. Poindexter and A.M. Dusick et al., Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age, Pediatrics 118 (2006), pp. e115–e123. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (66)

12 B.R. Vohr, B.B. Poindexter and A.M. Dusick et al., Persistent beneficial effects of breast milk ingested in the neonatal intensive care unit on outcomes of extremely low birth weight infants at 30 months of age, Pediatrics 120 (2007), pp. e953–e959. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (19)

13 D.L. O'Connor, J. Jacobs and R. Hall et al., Growth and development of premature infants fed predominantly human milk, predominantly premature infant formula, or a combination of human milk and premature formula, J Pediatr Gastroenterol Nutr 37 (2003), pp. 437–446. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (37)

14 J. Blaymore-Bier, T. Oliver and A. Ferguson et al., Human milk reduces outpatient upper respiratory symptoms in premature infants during their first year of life, J Perinatol 22 (2002), pp. 354–359. Full Text via CrossRef

15 A. Lucas, R. Morley and T.J. Cole et al., Breast milk and subsequent intelligence quotient in children born preterm, Lancet 339 (1992), pp. 261–264. Article | PDF (616 K) | View Record in Scopus | Cited By in Scopus (545)

16 E.B. Isaacs, B.R. Fischl and B.T. Quinn et al., Impact of breast milk on intelligence quotient, brain size, and white matter development, Pediatr Res 67 (2010), pp. 357–362. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (2)

17 L.J. Horwood and D.M. Fergusson, Breastfeeding and later cognitive and academic outcomes, Pediatrics 101 (1998), pp. E91–E97.

18 L.J. Horwood, N. Mogridge and B.A. Darlow, Cognitive, educational, and behavioral outcomes at 7 to 8 years in a national very low birthweight cohort, Arch Disord Child Fetal Neonat 79 (1998), pp. F12–F20. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (135)

19 L.J. Horwood, B.A. Darlow and N. Mogridge, Breast milk feeding and cognitive ability at 7-8 years, Arch Disord Child Fetal Neonat 84 (2001), pp. F23–F27. View Record in Scopus | Cited By in Scopus (64)

20 M. Hack, D.J. Flannery and M. Schluchter et al., Outcomes in young adulthood for very-low-birth-weight infants, N Engl J Med 346 (2002), pp. 149–157. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (363)

21 M.A. Hylander, D.M. Strobino and J.C. Pezzullo et al., Association of human milk feedings with a reduction in retinopathy of prematurity among very low birthweight infants, J Perinatol 21 (2001), pp. 356–362. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (42)

22 R.J. Schanler, C. Lau and N.M. Hurst et al., Randomized trial of donor human milk versus preterm formula as substitutes for mothers' own milk in the feeding of extremely premature infants, Pediatrics 116 (2005), pp. 400–406. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (83)

23 T. Okamoto, M. Shirai and M. Kokubo et al., Human milk reduces the risk of retinal detachment in extremely low-birthweight infants, Pediatr Int 49 (2007), pp. 894–897. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (5)

24 M. Hamosh, Bioactive factors in human milk, Pediatr Clin North Am 48 (2001), pp. 69–86. Article | PDF (958 K) | View Record in Scopus | Cited By in Scopus (81)

25 S. Polberger, Quality of growth in preterm neonates fed individually fortified human milk. In: F.C. Battaglia et al., Editors, Maternal and Extrauterine Nutritional Factors: Their Influence on Fetal and Infant Growth, Ediciones Ergon, Madrid (1996), pp. 395–403.

26 S. Kashyap, K.F. Schulze and M. Forsyth et al., Growth, nutrient retention, and metabolic response of low-birth-weight infants fed supplemented and unsupplemented preterm human milk, Am J Clin Nutr 52 (1990), pp. 254–262. View Record in Scopus | Cited By in Scopus (53)

27 S.K.T. Polberger, I.A. Axelsson and N.C.R. Raiha, Growth of very low birth weight infants on varying amounts of human milk protein, Pediatr Res 25 (1989), pp. 414–419. View Record in Scopus | Cited By in Scopus (41)

28 C.A. Kuschel and J.E. Harding, Protein supplementation of human milk for promoting growth in preterm infants, Cochrane Database Syst Rev 2 (1999), p. CD000433.

29 S.S. Premji, T. Fenton and R.S. Sauve, Higher versus lower protein intake in formula-fed low birthweight infants, Cochrane Database Syst Rev 1 (2006), p. CD003959. View Record in Scopus | Cited By in Scopus (3)

30 J.C. Rowe, D.H. Wood and D.W. Rowe et al., Nutritional hypophosphatemic rickets in a premature infant fed breast milk, N Engl J Med 300 (1979), pp. 293–296. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (28)

31 J.M. Pettifor, H. Stein and A. Herman, Mineral homeostasis in very low birth weight infants fed either own mother's milk or pooled pasteurized preterm milk, J Pediatr Gastroenterol Nutr 5 (1986), pp. 248–253. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (3)

32 A. Lucas, O.G. Brooke and B.A. Baker et al., High alkaline phosphatase activity and growth in preterm neonates, Arch Dis Child 64 (1989), pp. 902–909. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (54)

33 M.S. Fewtrell, T.J. Cole and N.J. Bishop et al., Neonatal factors predicting childhood height in preterm infants: evidence for a persisting effect of early metabolic bone disease?, J Pediatr 137 (2000), pp. 668–673. Abstract | PDF (72 K) | View Record in Scopus | Cited By in Scopus (51)

34 R.J. Schanler and C. Garza, Improved mineral balance in very low birth weight infants fed fortified human milk, J Pediatr 112 (1987), pp. 452–456.

35 C.A. Kuschel and J.E. Harding, Multicomponent Fortified Human Milk for Promoting Growth in Preterm Infants, Cochrane Database Syst Rev 1 (2004), p. CD000343. View Record in Scopus | Cited By in Scopus (11)

36 R.A. Ehrenkranz, A.M. Dusick and B.R. Vohr et al., Growth in the neonatal intensive care unit influence neurodevelopmental and growth outcomes of extremely low birth weight infants, Pediatrics 117 (2006), pp. 1253–1261. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (97)

37 A. Lucas and A. Lucas, Long-term programming effects of early nutrition—implications for the preterm infant, J Perinatol 25 (2005), pp. S2–S6. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (51)

38 A. Singhal, I.S. Farooqi and S. O'Rahilly et al., Early nutrition and leptin concentrations in later life, Am J Clin Nutr 75 (2002), pp. 993–999. View Record in Scopus | Cited By in Scopus (86)

39 A. Singhal, M. Fewtrell and T.J. Cole et al., Low nutrient intake and early growth for later insulin resistance in adolescents born preterm, Lancet 361 (2003), pp. 1089–1097. Article | PDF (116 K) | View Record in Scopus | Cited By in Scopus (190)

40 A. Singhal, T.J. Cole and A. Lucas, Early nutrition in preterm infants and later blood pressure: two cohorts after randomized trials, Lancet 357 (2001), pp. 413–419. Article | PDF (437 K) | View Record in Scopus | Cited By in Scopus (214)

41 J.A. Mennella, C.E. Griffin and G.K. Beauchamp, Flavor programming during infancy, Pediatrics 113 (2004), pp. 840–845. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (41)

42 P.A. Schoknecht, S. Ebner and W.G. Pond et al., Dietary cholesterol supplementation improves growth and behavioral response of pigs selected for genetically high and low serum cholesterol, J Nutr 124 (1994), pp. 305–314. View Record in Scopus | Cited By in Scopus (17)

43 C.G. Owen, P.H. Whincup and K. Odoki et al., Infant feeding and blood cholesterol: a study in adolescents and a systematic review, Pediatrics 110 (2002), pp. 597–608. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (111)

44 R. Uauy, D. Hoffman and P. Peirano et al., Essential fatty acids in visual and brain development, Lipids 36 (2001), pp. 885–895. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (146)

45 L. Bode, Recent advances on structure, metabolism, and function of human milk oligosaccharides, J Nutr 136 (2006), pp. 2127–2130. View Record in Scopus | Cited By in Scopus (41)


Corresponding Author Contact InformationAddress reprint requests to Richard J. Schanler, MD, FAAP, FABM, Neonatal-Perinatal Medicine, North Shore University Hospital, 300 Community Drive, Manhasset, NY 11030



请登录后发表评论,点击此处登录。

慢性心衰诊治:规范中求突破
黄峻
2012-2-1
南京医科大学第一附属医院
房颤治疗:手段渐趋丰富 新型治疗药物不断涌现 非药物治疗备受关注
马长生
2012-2-1
首都医科大学附属北京安贞医院
注重老年人群特征 优化管理

刘梅林
2012-2-1
北京大学第一医院老年内科

 

相关文章

关注糖尿病,聚焦GLP-1!案例征集大赛

时间:2011-3~~2011-11
由中国医师协会主办、礼来国际贸易(上海)有限公司协办、爱思唯尔国际出版集团承办的“精彩案例我分享——关注糖尿病•聚焦GLP-1”案例征集活动将于2011年3月~ 11月在全国范围隆重展开。

关注青光眼患者, 让世界更明亮!

时间:2011-4~~2011-12
《中华眼科杂志》发起,辉瑞制药资助,旨在交流青光眼治疗理念,分享国内抗青光眼药物固定联合治疗经验的病例交流活动.

聚焦哮喘和COPD联合制剂治疗

时间:2010-12~~2011-12
哮喘和慢性阻塞性肺疾病(COPD)是常见、多发的气道炎症性疾病,这类疾病严重影响患者的生活质量。我们特别组织了该类案例征集活动,奖品丰厚,快来参与!

中国选择 达标看我

时间:2011-9~~2012-9
本次活动对典型病例以分享的形式总结临床经验,通过跨专科、多层次的学术交流,对降压治疗方案、疗效进行解析与点评。